FDA_16-223-SOL-1158666_Sources_Sought_Notification.pdf

THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR

WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION

ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED

FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR

ANY COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO

THIS ANNOUNCEMENT OR ANY FOLLOW-UP INFORMATION REQUESTS. NO

TELEPHONE CALLS WILL BE ACCEPTED REQUESTING AN RFQ PACKAGE OR

SOLICITATION. THERE IS NO RFQ PACKAGE OR SOLICITATION. IN ORDER TO

PROTECT THE PROCUREMENT INTEGRITY OF ANY FUTURE PROCUREMENT,

IF ANY, THAT MAY ARISE FROM THIS ANNOUNCEMENT, INFORMATION

REGARDING THE TECHNICAL POINT OF CONTACT WILL NOT BE GIVEN AND

NO APPOINTMENTS FOR PRESENTATIONS WILL BE MADE.

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) has issued this sources sought announcement on behalf of the Center for Biologics Evaluation and Research (CBER) in order to determine if there are existing small business sources capable of providing annual preventive and corrective maintenance services for the following Equipment: HiSeq 2500 (Serial Number: 7001029), MiSeq (Serial Number:M01542), cBOT (Serial Number: 6001205), and iCompute (Serial Number: IC-51132863) (Base + 3 1-year Maintenance Option periods).

If your firm is considered a small business source under North American Industry Classification System (NAICS) 811219 – Other Electronic and Precision Equipment Repair and Maintenance;

with a Small Business Size Standard of $20.5 Million, and believe that your firm would be able to provide the FDA with the services described below, please submit an email to Yolanda.peer@fda.hhs.gov. The vendor should include information about the company and demonstrate that it can meet all of the minimum performance requirements.

Background: The FDA/CBER currently owns the following equipment: HiSeq 2500 (Serial Number: 7001029), MiSeq (Serial Number:M01542), cBOT (Serial Number: 60012053), and iCompute (Serial Number: IC-51132863). The equipment is currently covered under Purchase Order: HHSF223201110060A and the Maintenance agreement will expire on November 2, 2015 and the iCompute Maintenance agreement will expire on November 11, 2015. The Center for Biologics Evaluation and Research conducts research as well as perform regulatory functions. To meet the needs of deoxyribonucleic acid (DNA) sequencing efforts using next generation sequencing (NGS), the Facility for Biotechnology Resources (FBR) is equipped with an llumina HiSeq 2500 and Mi-Seq next generation sequencers and is providing NGS services for CBER scientists. The success of NGS relies greatly on how DNA is efficiently extracted, fragmented into desired-size fragments. The adequately-sized DNA templates are then amplified to generate multiple copies for each individual fragment (called “ library”) before the sequencing reaction is carried out. FBR uses an Illumina cBOT for efficient library generation. The data generated in a sequencer is huge requiring data server for converting to useful files and mapping to a database. This is done by using Illunina iComputer. Both Illumina HiSeq2500, MiSeq, and cBOT, as well as iCompute are therefore essential instruments for CBER’s next generation sequencing service.

These systems are operative on a daily basis and is in need of a Preventive and Corrective Maintenance agreement.

Minimum Performance Requirements:

• All Preventative Maintenance (PM) and repair activities shall be performed by formally trained and certified technicians/engineers.

• All repair and services shall be performed following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins using OEM replacement parts, components subassemblies, etc.

• Pricing for all repair and PM services shall be inclusive of labor, travel, replacement parts, components, subassemblies etc.

• Shall include unlimited corrective/remedial maintenance visits within 5 business days of call for service.

• The service plan shall include at least one (1) on-site PM visit per year.

• Shall include unlimited technical support (e.g., telephone-based, emails-based, website-base, etc.), Mondays – Fridays (excluding Federal Holidays) between the hours of 7:00 AM –

5:00 PM Eastern Time.

• Shall include critical and non-critical hardware and software updates, application supports, and access to online training modules.

• Shall offer replacement reagent kits, in the event of hardware failure

Period of Performance: (Base + 3-year Option period)

Base: 12/07/2015 thru 12/06/2016

Option Year 1: 12/07/2016 thru 12/06/2017 Option Year 2: 12/07/2017 thru 12/06/2018 Option Year 3: 12/07/2018 thru 12/06/2019

Place of Performance:

Food and Drug Administration Center for Biologics Evaluation and Research 10903 New Hampshire Avenue Building 52/72, Room 1106 Silver Spring, MD 20993

Service Records and Reports

The Contractor shall, commensurate with the completion of each service call (inclusive of warranty service), provide the end-user of the equipment with a copy of a field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment being serviced/repaired and detailing the reason for the service call, a detailed description of the work performed, the test instruments or other equipment used to affect the repair or otherwise perform the service, the name(s) and contact information of the technician who performed the repair/service, and for information purposes, the on-site hours expended and parts/components replaced. In addition, the Contractor shall provide a written report to the FDA COR and Contract Specialist, summarizing all maintenance and repair activities (including warranty work) each time service and/or repair is performed.

Responses to this sources sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially similar service. Though the target audience is small business or small businesses capable of providing service from another small business, all interested parties may respond. At a minimum, responses shall include the following:

• Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm.

• Past Performance information for the manufacturer and/or sale of same or substantially similar service or similar brand instruments to include date of sale, description, dollar value, client name, client address, client contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent.

• Descriptive literature, brochures, marketing material, etc. detailing the nature of the service the responding firm is regularly engaged in manufacturing and/or selling.

• If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested. If a large business, provide if subcontracting opportunities exist for small business concerns. The Government is not responsible for locating or securing any information, not identified in the response.

Interested Contractors must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before November 16, 2015 by 13:00 hours (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, Field Operations Branch, FDA|OO|OFBA|OAGS|DAP, Attn: Yolanda Peer, 3900 NCTR Road, HFT‐320, Bldg. 50, Rm 420 Jefferson, AR 72079‐9502 or email yolanda.peer@fda.hhs.gov. Reference: FDA_16-223-SOL-1158666.

Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis and solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response.

The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).

Additional Notes: If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service would be helpful.